A method for obtaining randomized block designs in preclinical studies with multiple quantitative blocking variables.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 2, p. 169, doi. 10.1002/pst.445
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2011 AND VI 10 AND IP 2
Results: 16
1
2
Adaptive design theory and implementation using SAS and R Mark Chang (2007) ISBN 1584889624; 440 pages; £48.99, $89.95 Chapman & Hall/CRC;.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 2, p. 185, doi. 10.1002/pst.371
- By:
- Publication type:
- Article
3
Statistical resource needs to be increased in the European regulatory agencies.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 2, p. 87, doi. 10.1002/pst.416
- By:
- Publication type:
- Article
4
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 2, p. 150, doi. 10.1002/pst.433
- By:
- Publication type:
- Article
5
Reference regions for beat-to-beat ECG data.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 2, p. 162, doi. 10.1002/pst.444
- By:
- Publication type:
- Article
6
Guidelines for accurate EC50/IC50 estimation.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 2, p. 128, doi. 10.1002/pst.426
- By:
- Publication type:
- Article
7
The correlation structure of longitudinal measurements of vision in patients with macular degeneration.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 2, p. 115, doi. 10.1002/pst.419
- By:
- Publication type:
- Article
8
Adapting by calibration the sample size of a phase III trial on the basis of phase II data.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 2, p. 89, doi. 10.1002/pst.410
- By:
- Publication type:
- Article
9
Literature Review October-December 2010.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 2, p. 183, doi. 10.1002/pst.490
- By:
- Publication type:
- Article
10
Fitting E.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 2, p. 143, doi. 10.1002/pst.432
- By:
- Publication type:
- Article
11
Erratum: Evaluations of Bayesian and maximum likelihood methods in PK models with below-quantification-limit data.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 2, p. 187, doi. 10.1002/pst.436
- By:
- Publication type:
- Article
12
A course for clinical trial personnel in clinical study designs, randomization, allocation schedules, and interactive response systems.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 2, p. 175, doi. 10.1002/pst.447
- By:
- Publication type:
- Article
13
An alternative phase II/III design for continuous endpoints.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 2, p. 105, doi. 10.1002/pst.418
- By:
- Publication type:
- Article
14
A flexible class of models for data arising from a 'thorough QT/QTc study'.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 2, p. 122, doi. 10.1002/pst.420
- By:
- Publication type:
- Article
15
The effect of variability and carryover on average bioequivalence assessment: A simulation study.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 2, p. 135, doi. 10.1002/pst.431
- By:
- Publication type:
- Article
16
Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 2, p. 96, doi. 10.1002/pst.413
- By:
- Publication type:
- Article